§ EQUITY
USDORMP
ORAMED PHARMACEUTICALS INC
USD
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
OPEN 3.90HIGH 3.90LOW 3.83
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
51 increased/new, 19 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| BML Capital Management, LLC | 3.2M | 6.9% | ±0% |
| Aquamarine Financial (Cayman) Ltd | 2.1M | 0.5% | +7% |
| MERCER GLOBAL ADVISORS INC /ADV | 1.9M | 0.0% | n/a |
| Gem Investment Advisors, LLC | 1.6M | 5.5% | −18% |
| Murchinson Ltd. | 1.3M | 0.6% | −2% |
| BOOTHBAY FUND MANAGEMENT, LLC | 601K | 0.0% | −2% |
◇ AC INTELLIGENCE
Top institutional owners for ORMP as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER90.2% · 43 holders
SYSTEMATIC / QUANT3.2% · 3 holders
DEALER / BANK2.9% · 10 holders
QUALITY / COMPOUNDER1.4% · 3 holders
TACTICAL / MACRO1.3% · 3 holders
PASSIVE / INDEX0.9% · 2 holders
INCOME / DEFENSIVE0.0% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for ORMP in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention ORMP yet.